Key points are not available for this paper at this time.
Long-term PPI therapy, particularly at high doses, is associated with an increased risk of hip fracture.
Yang et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: